Harrow Historical Cash Flow
| HROW Stock | USD 10.85 0.97 8.21% |
Analysis of Harrow Health cash flow over time is an excellent tool to project Harrow Health future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 53.1 M or Capital Expenditures of 160.2 M as it is a great indicator of Harrow Health ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Harrow Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Harrow Health is a good buy for the upcoming year.
Harrow |
About Harrow Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Harrow balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Harrow's non-liquid assets can be easily converted into cash.
Harrow Health Cash Flow Chart
Harrow Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Harrow Health Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
At this time, Harrow Health's Net Borrowings is fairly stable compared to the past year. Cash And Cash Equivalents Changes is likely to climb to about 65.3 M in 2024, despite the fact that Change In Cash is likely to grow to (21.1 M). Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Harrow Health's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Harrow Health current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.At this time, Harrow Health's Net Borrowings is fairly stable compared to the past year. Cash And Cash Equivalents Changes is likely to climb to about 65.3 M in 2024, despite the fact that Change In Cash is likely to grow to (21.1 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Depreciation | 2.4M | 3.7M | 12.3M | 13.0M | Stock Based Compensation | 5.7M | 8.0M | 15.7M | 16.5M |
Harrow Health cash flow statement Correlations
Click cells to compare fundamentals
Harrow Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Harrow Health cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 769K | (29K) | (11M) | (876K) | (788.4K) | (749.0K) | |
| Change In Cash | (1.9M) | (648K) | 37.9M | 54.1M | (22.2M) | (21.1M) | |
| Free Cash Flow | (887K) | (2.1M) | (23.4M) | (6.1M) | (148.7M) | (141.3M) | |
| Change In Working Capital | (1.7M) | (6.3M) | (253K) | (5.6M) | (7.1M) | (6.8M) | |
| Other Cashflows From Financing Activities | (282K) | 3.1M | (19.2M) | 33.3M | 136.3M | 143.1M | |
| Other Non Cash Items | 512K | 815K | 677K | 9.7M | 50.6M | 53.1M | |
| Capital Expenditures | 1.8M | 994K | 28.5M | 7.8M | 152.6M | 160.2M | |
| Total Cash From Operating Activities | 950K | (1.1M) | 5.1M | 1.7M | 3.8M | 4.0M | |
| Net Income | (125K) | (3.4M) | (18.0M) | (14.1M) | (24.4M) | (23.2M) | |
| Total Cash From Financing Activities | (1.0M) | 1.4M | 51.5M | 54.1M | 126.5M | 132.9M | |
| End Period Cash Flow | 4.9M | 4.3M | 42.2M | 96.3M | 74.1M | 77.8M | |
| Stock Based Compensation | 2.0M | 2.9M | 5.7M | 8.0M | 15.7M | 16.5M | |
| Depreciation | 2.7M | 2.7M | 2.4M | 3.7M | 12.3M | 13.0M | |
| Net Borrowings | (750K) | 1.5M | 55.1M | 31.7M | 36.5M | 38.3M | |
| Cash And Cash Equivalents Changes | (1.9M) | (648K) | 37.9M | 54.1M | 62.2M | 65.3M | |
| Cash Flows Other Operating | (15K) | 2.4M | 13.8M | 2.4M | 2.8M | 1.7M | |
| Change To Netincome | (377K) | 3.5M | 6.5M | 11.0M | 12.6M | 13.2M | |
| Change To Liabilities | 1.2M | (4.5M) | 2.5M | 2.8M | 3.2M | 3.4M | |
| Total Cashflows From Investing Activities | (1.8M) | (981K) | (18.7M) | (1.7M) | (1.6M) | (1.6M) | |
| Investments | (1.8M) | (981K) | (2.8M) | (1.7M) | (152.6M) | (144.9M) | |
| Change To Inventory | (2.3M) | (661K) | (255K) | (2.3M) | (4.3M) | (4.1M) | |
| Change Receivables | (95K) | (866K) | (1.8M) | (1.9M) | (1.7M) | (1.6M) | |
| Change To Account Receivables | (95K) | (866K) | (1.8M) | (1.9M) | (30.3M) | (28.8M) | |
| Change To Operating Activities | 951K | (637K) | (96K) | 153K | 137.7K | 144.6K | |
| Other Cashflows From Investing Activities | (365K) | (119K) | (14.1M) | 854K | 768.6K | 807.0K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Harrow Stock analysis
When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stocks Directory Find actively traded stocks across global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Harrow Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.64) | Earnings Share (0.75) | Revenue Per Share 3.992 | Quarterly Revenue Growth 0.788 | Return On Assets 0.0022 |
The market value of Harrow Health is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.